Clinical trial
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
NCT06553625 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 29, 2024
- Completion date
- December 31, 2035
- Enrollment
- 200 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.